FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323033666> ?p ?o ?g. }

• W4323033666 endingPage "109952" @default.
• W4323033666 startingPage "109952" @default.
• W4323033666 abstract "Thymosin alpha 1 (Tα1) is a highly conserved 28 amino-acid peptide naturally occurring in the thymus and plays critical roles in T cell maturity and differentiation. Its synthetic form, thymalfasin, has been approved by various regulatory agencies in the treatment of hepatitis B viral infection and as an enhancer of vaccine response in immune-compromised populations. In China, it has also widely utilized in patients with cancer and severe infections, as well as the emergency use during (Severe Acute Respiratory Syndrome)SARS and COVID-19 pandemic as an immune-regulator. Recent studies showed that Tα1 could significantly improve overall survival (OS) in patients with surgically resectable non-small cell lung cancer (NSCLC) and liver cancers in the adjuvant setting. For patients with locally advanced, unresectable NSCLC, Tα1 could significantly reduce chemoradiation-induced lymphopenia, pneumonia, and trending improvement of OS. Preclinical evidence are emerging to demonstrate that Tα1 may augment efficacy of cancer chemotherapy by reversing efferocytosis-induced M2 polarization of macrophages via activation of a TLR7/SHIP1 axis and enhancing anti-tumor immunity by turning cold-tumors to hot-tumors; a protective role in reducing colitis caused by immune check-point inhibitors (ICIs). Potential enhancement of ICIs' clinical efficacies has also been indicated. ICIs have transformed ways treating patients with cancer but limitations such as relatively low response rates and certain safety issues remains. Given the roles of Tα1 in regulating cellular immunities and exceptional safety profiles demonstrated in decades clinical uses, we believe that it is plausible to explore implications of Tα1 the immune-oncology setting by combining with ICI-based therapeutic strategies. Background Activities of Tα1. Tα1 is a biological response modifier which activates various cells in the immune system [1-3]. Tα1 is therefore expected to have clinical benefits in disorders where immune responses are impaired or ineffective. These disorders include acute and chronic infections, cancers, and vaccine non-responsiveness. In severe sepsis, for example, sepsis-induced immunosuppression is increasingly recognized as the overriding immune dysfunction in these vulnerable patients [4] and there is now agreement that many patients with severe sepsis survive the first critical hours of the syndrome but eventually die later due to patients' immunosuppression which make the system difficulty to fight the primary bacterial infection, decreased resistance to secondary nosocomial infections, and reactivation of viral infections [5]. Tα1 has been shown to restore immune functions and help to reduce mortality in patients with severe sepsis." @default.
• W4323033666 created "2023-03-04" @default.
• W4323033666 creator A5023135321 @default.
• W4323033666 date "2023-04-01" @default.
• W4323033666 modified "2023-10-14" @default.
• W4323033666 title "Thymosin alpha 1 – Reimagine its broader applications in the immuno-oncology era" @default.
• W4323033666 cites W1509386918 @default.
• W4323033666 cites W1977905350 @default.
• W4323033666 cites W2100258681 @default.
• W4323033666 cites W2113743031 @default.
• W4323033666 cites W2149080433 @default.
• W4323033666 cites W2150855780 @default.
• W4323033666 cites W2159841134 @default.
• W4323033666 cites W2160329277 @default.
• W4323033666 cites W2753065806 @default.
• W4323033666 cites W2886586625 @default.
• W4323033666 cites W2897521722 @default.
• W4323033666 cites W2955663214 @default.
• W4323033666 cites W2977255036 @default.
• W4323033666 cites W3043942728 @default.
• W4323033666 cites W3046914523 @default.
• W4323033666 cites W3049688531 @default.
• W4323033666 cites W3123313279 @default.
• W4323033666 cites W4211168024 @default.
• W4323033666 cites W4224311924 @default.
• W4323033666 cites W4226422922 @default.
• W4323033666 cites W4248288228 @default.
• W4323033666 cites W4286267598 @default.
• W4323033666 doi "https://doi.org/10.1016/j.intimp.2023.109952" @default.
• W4323033666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36871535" @default.
• W4323033666 hasPublicationYear "2023" @default.
• W4323033666 type Work @default.
• W4323033666 citedByCount "0" @default.
• W4323033666 crossrefType "journal-article" @default.
• W4323033666 hasAuthorship W4323033666A5023135321 @default.
• W4323033666 hasConcept C121608353 @default.
• W4323033666 hasConcept C126322002 @default.
• W4323033666 hasConcept C143998085 @default.
• W4323033666 hasConcept C203014093 @default.
• W4323033666 hasConcept C2776451592 @default.
• W4323033666 hasConcept C2777701055 @default.
• W4323033666 hasConcept C2777863537 @default.
• W4323033666 hasConcept C2777877232 @default.
• W4323033666 hasConcept C502942594 @default.
• W4323033666 hasConcept C71924100 @default.
• W4323033666 hasConcept C8891405 @default.
• W4323033666 hasConceptScore W4323033666C121608353 @default.
• W4323033666 hasConceptScore W4323033666C126322002 @default.
• W4323033666 hasConceptScore W4323033666C143998085 @default.
• W4323033666 hasConceptScore W4323033666C203014093 @default.
• W4323033666 hasConceptScore W4323033666C2776451592 @default.
• W4323033666 hasConceptScore W4323033666C2777701055 @default.
• W4323033666 hasConceptScore W4323033666C2777863537 @default.
• W4323033666 hasConceptScore W4323033666C2777877232 @default.
• W4323033666 hasConceptScore W4323033666C502942594 @default.
• W4323033666 hasConceptScore W4323033666C71924100 @default.
• W4323033666 hasConceptScore W4323033666C8891405 @default.
• W4323033666 hasLocation W43230336661 @default.
• W4323033666 hasLocation W43230336662 @default.
• W4323033666 hasOpenAccess W4323033666 @default.
• W4323033666 hasPrimaryLocation W43230336661 @default.
• W4323033666 hasRelatedWork W1986962886 @default.
• W4323033666 hasRelatedWork W1996150995 @default.
• W4323033666 hasRelatedWork W2090324576 @default.
• W4323033666 hasRelatedWork W2150904395 @default.
• W4323033666 hasRelatedWork W3202463490 @default.
• W4323033666 hasRelatedWork W4250535920 @default.
• W4323033666 hasRelatedWork W4310146411 @default.
• W4323033666 hasRelatedWork W4360983034 @default.
• W4323033666 hasRelatedWork W4379467849 @default.
• W4323033666 hasRelatedWork W68488667 @default.
• W4323033666 hasVolume "117" @default.
• W4323033666 isParatext "false" @default.
• W4323033666 isRetracted "false" @default.
• W4323033666 workType "article" @default.